Introduction to special section on using pools to generate Good Laboratory Practice tox or other non-clinical material to accelerate development timelines

Biotechnol Prog. 2017 Nov;33(6):1435. doi: 10.1002/btpr.2583. Epub 2017 Nov 28.

Authors

Christine DeMaria¹, Trent Munro²

Affiliations

¹ Cell Line Development, Global Biopharmaceutics Development, Sanofi, Framingham, MA, 01701.
² Attribute Sciences, Process Development, Amgen, Thousand Oaks, CA, 91320.

PMID: 29193815
DOI: 10.1002/btpr.2583

No abstract available

Publication types

Editorial

MeSH terms

Animals
Biotechnology / trends*
CHO Cells / drug effects
CHO Cells / metabolism*
Cricetulus
Drug Therapy / trends
Drug-Related Side Effects and Adverse Reactions / metabolism*
Humans
Toxicology / trends*